Correlation Between NewAmsterdam Pharma and Aytu BioScience
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Aytu BioScience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Aytu BioScience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Aytu BioScience, you can compare the effects of market volatilities on NewAmsterdam Pharma and Aytu BioScience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Aytu BioScience. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Aytu BioScience.
Diversification Opportunities for NewAmsterdam Pharma and Aytu BioScience
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between NewAmsterdam and Aytu is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Aytu BioScience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aytu BioScience and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Aytu BioScience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aytu BioScience has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Aytu BioScience go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Aytu BioScience
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 1.29 times more return on investment than Aytu BioScience. However, NewAmsterdam Pharma is 1.29 times more volatile than Aytu BioScience. It trades about 0.01 of its potential returns per unit of risk. Aytu BioScience is currently generating about -0.13 per unit of risk. If you would invest 1,892 in NewAmsterdam Pharma on November 28, 2024 and sell it today you would lose (104.00) from holding NewAmsterdam Pharma or give up 5.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Aytu BioScience
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Aytu BioScience |
NewAmsterdam Pharma and Aytu BioScience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Aytu BioScience
The main advantage of trading using opposite NewAmsterdam Pharma and Aytu BioScience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Aytu BioScience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will offset losses from the drop in Aytu BioScience's long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Aytu BioScience vs. Aquestive Therapeutics | Aytu BioScience vs. Evoke Pharma | Aytu BioScience vs. Shionogi Co Ltd | Aytu BioScience vs. Sunshine Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |